Cancer Research and Treatment

Lung cancer, comorbidities, and medication: the infernal trio

Hélène Pluchart, Sébastien Chanoine, Denis Moro-Sibilot, Christos Chouaid, Gil Frey, Julie Villa, Bruno Degano, Matteo Giaj Levra, Pierrick Bedouch, Anne-Claire Toffart

Stratification of Risk Factors of Lung Cancer-Associated Venous Thromboembolism and Determining the Critical Point for Preemptive Intervention: A Systematic Review With Meta-analysis

Clinical Medicine Insights: Oncology.2023;[Epub] CrossRef

Seratrodast platinum(iv) hybrids efficiently inhibit cancer-related thrombosis and metastasis phenotype in vitro and in vivo

Xue-Qing Song, Yi-Xin Ding, Yu-Hang Zhang, Qing Xu, Xiaofeng Xie, Yali Song, Longfei Li

Inorganic Chemistry Frontiers.2023; 10(22): 6596. CrossRef

Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin

Hundo Cho, Jin-Hyuk Choi, Seok Yun Kang, Hyun Woo Lee, Yong Won Choi, Tae-Hwan Kim, Mi Sun Ahn, Chul-Ho Kim, Yoo Seob Shin, Jeon Yeob Jang, Young-Taek Oh, Jaesung Heo, Seung Soo Sheen

The Korean Journal of Internal Medicine.2022; 37(3): 653. CrossRef

Analysis of thromboembolic events in patients with non-small cell lung cancer who received adjuvant chemotherapy: single-center real-world data

Tae-Hwan Kim, Yong Won Choi, Hyun Woo Lee, Seok Yun Kang, Heejun Son, Jin-Hyuk Choi, Mi Sun Ahn, Seung-Soo Sheen

Embolic Stroke Due to a Mural Thrombus in the Ascending Aorta Following Cisplatin-based Chemotherapy

Effect of thromboprophylaxis on the incidence of venous thromboembolism in surgical patients with colorectal cancer: a meta-analysis

Evaluation of Biomarkers for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients

Ruth Maria Schorling, Christian Pfrepper, Thomas Golombek, Chiara Alessandra Cella, Nerea Muñoz-Unceta, Roland Siegemund, Christoph Engel, Sirak Petros, Florian Lordick, Maren Knödler

Oncology Research and Treatment.2020; 43(9): 414. CrossRef

Aortic Mural Thrombus in the Non-atherosclerotic Aorta of Patients with Multiple Hypercoagulable Factors

Takeshi Yagyu, Maiko Naito, Masahiro Kumada, Tsutomu Nakagawa

Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models

Silvia Riondino, Patrizia Ferroni, Fabio Zanzotto, Mario Roselli, Fiorella Guadagni

Altered fibrin clot properties in advanced lung cancer: strong impact of cigarette smoking

Michał Ząbczyk, Grzegorz Królczyk, Grzegorz Czyżewicz, Krzysztof Plens, Shannon Prior, Saulius Butenas, Anetta Undas

New data for venous thromboembolism in patients with small cell lung cancer: A review

Evangelos Dimakakos, Konstantinos Livanios, Ioannis Gkiozos, Adriani Charpidou, Eleutheria Ntalakou, llias Kainis, Konstantinos Syrigos

Phlebology: The Journal of Venous Disease.2018; 33(8): 517. CrossRef

Diagnosis, Treatment, and Prevention of Cardiovascular Toxicity Related to Anti-Cancer Treatment in Clinical Practice: An Opinion Paper from the Working Group on Cardio-Oncology of the Korean Society of Echocardiography

Hyungseop Kim, Woo-Baek Chung, Kyoung Im Cho, Bong-Joon Kim, Jeong-Sook Seo, Seong-Mi Park, Hak Jin Kim, Ju-Hee Lee, Eun Kyoung Kim, Ho-Joong Youn

Journal of Cardiovascular Ultrasound.2018; 26(1): 1. CrossRef

Venous thromboembolic events in patients with lung cancer treated with cisplatin-based versus carboplatin/nedaplatin-based chemotherapy

Akihisa Mitani, Taisuke Jo, Hideo Yasunaga, Yukiyo Sakamoto, Wakae Hasegawa, Hirokazu Urushiyama, Yasuhiro Yamauchi, Hiroki Matsui, Kiyohide Fushimi, Takahide Nagase

Long-Term Risk of Venous Thromboembolism in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study

Arin L. Madenci, Brent R. Weil, Qi Liu, Andrew J. Murphy, Todd M. Gibson, Yutaka Yasui, Wendy M. Leisenring, Rebecca M. Howell, Christopher L. Tinkle, Larissa Nekhlyudov, Lisa R. Diller, Gregory T. Armstrong, Kevin C. Oeffinger, Christopher B. Weldon

Journal of Clinical Oncology.2018; 36(31): 3144. CrossRef

Beneficial effect of additional treatment with�widely�available anticancer agents in advanced small�lung cell carcinoma: A case report

Molecular and Clinical Oncology.2018;[Epub] CrossRef

Cancer-associated venous thromboembolism: Burden, mechanisms, and management

Thrombosis and Haemostasis.2017; 117(02): 219. CrossRef

Mutational status predicts the risk of thromboembolic events in lung adenocarcinoma

Elsa Davidsson, Nicola Murgia, Cristian Ortiz-Villalón, Emil Wiklundh, Magnus Sköld, Karl Gustav Kölbeck, Giovanni Ferrara

Multidisciplinary Respiratory Medicine.2017;[Epub] CrossRef

Validation of a Machine Learning Approach for Venous Thromboembolism Risk Prediction in Oncology

Patrizia Ferroni, Fabio M. Zanzotto, Noemi Scarpato, Silvia Riondino, Fiorella Guadagni, Mario Roselli

Severe intestinal ischemia during chemotherapy for small cell lung cancer

Epidemiology and risk factors for venous thromboembolism in lung cancer

Current Opinion in Oncology.2016; 28(2): 145. CrossRef

A systematic review of biomarkers for the prediction of thromboembolism in lung cancer — Results, practical issues and proposed strategies for future risk prediction models